Scholars Central

CommentaryPublished 26 Jul 2020

Gemcitabine-carbon nitride dots as nanocarrier to target specifically pediatric glioma tumors

Authors: Roger M. Leblanc, Piumi Y. Liyanage

Hematology and Blood Disorders

Volume 3 · Issue 2 · Pages 33–35

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The article discusses a study to target-specific gemcitabine delivery to pediatric glioblastoma tumors across the blood-brain barrier (BBB) using carbon nitride dots (CNDs) as a nanocarrier . CNDs can be identified as a third-generation novel nano dot material after semiconductor metal quantum dots and carbon dots. Similar to its predecessor carbon dots, CNDs have excellent stability, water dispersibility and non-toxic properties in comparison to the metal quantum dots.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHematology and Blood Disorders
  • SubjectHaematology
  • BylineArticles whose byline prints “Roger M. Leblanc”
  • BylineArticles whose byline prints “Piumi Y. Liyanage”